Recently, the China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE) announced the second batch of Certificate of Export Commodity Brand list recommended by the chamber of Commerce for medical insurance in 2022. CCPIT commercial certification center once again issued brand certificates for export commodities for 12 medical and health enterprises, including:

Beijing WANTAI Biological Pharmacy Enterprise Co.,Ltd., 2022 CACLP booth No.: A2-2909

Hangzhou Biotest Biotech Co.,Ltd., 2022 CACLP booth No.: B3-2909

Lansion Biotechnology Co.,Ltd, 2022 CACLP booth No.: A2-0115

GenSure Biotech Inc., 2022 CACLP booth No.: A1-3320

Maccura Biotechnology Co.,Ltd., 2022 CACLP booth No.: A3-2801

Xi'an TianLong Science & Technology Co.,Ltd., 2022 CACLP booth No.: A4-2814

SHENZHEN YHLO BIOTECH Co.,Ltd., 2022 CACLP booth No.: A4-2109

The brand evaluation of export commodities refers to the evaluation conducted by the commercial certification center of CCPIT on the export brands of enterprises in accordance with the group standard t/ccpitcsc015-2018 specification for brand evaluation of export commodities from the eight dimensions of R & D and innovation ability, international certification, market recognition, intellectual property protection, global operation, credit system, social evaluation and departmental punishment, and the issuance of export commodity brand certificate for qualified enterprises. The legitimacy and validity of the export commodity brand certificate has been recognized by more than 200 countries and regions in the world.